Imagion Biosystems Ltd
ASX:IBX

Watchlist Manager
Imagion Biosystems Ltd Logo
Imagion Biosystems Ltd
ASX:IBX
Watchlist
Price: 0.028 AUD
Market Cap: 12.3m AUD
Section:
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

IBX doesn't have a meaningful market cap.

The Relative Value of one IBX stock under the Base Case scenario is 0.007 AUD. Compared to the current market price of 0.028 AUD, Imagion Biosystems Ltd is Overvalued by 74%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IBX Relative Value
Base Case
0.007 AUD
Overvaluation 74%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

11.6
P/S
P/S
Price to Sales
11.6
vs History
66
vs Industry
38
Median 3Y
22.6
Median 5Y
522.9
Industry
2.4
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-5.6
Median 5Y
-30.4
Industry
22.6
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-9.3
Median 5Y
-36.9
Industry
14.6
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-13.7
Median 5Y
-34.4
Industry
21.8
More Details
Negative
P/B
P/B
Price to Book Value
N/A
vs History
vs Industry
35
Median 3Y
-3.3
Median 5Y
56.2
Industry
2.3
More Details
13.9
EV/S
EV/S
Enterprise Value to Sales
13.9
vs History
66
vs Industry
36
Median 3Y
25.9
Median 5Y
521.4
Industry
2.6
More Details
N/A
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.2
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-10.1
Median 5Y
-24.5
Industry
12
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-10.1
Median 5Y
-24.5
Industry
16.6
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-10.4
Median 5Y
-36.8
Industry
14.9
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-9.8
Median 5Y
-34.6
Industry
19
More Details
Negative
EV/IC
EV/IC
Enterprise Value to IC
N/A
vs History
vs Industry
24
Median 3Y
17.3
Median 5Y
74.6
Industry
1.9
More Details

Multiples Across Competitors

IBX Competitors Multiples
Imagion Biosystems Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Imagion Biosystems Ltd
ASX:IBX
12.3m AUD 11.6 -5.6 -15 -15
US
Abbott Laboratories
NYSE:ABT
220.8B USD 5 15.8 20.3 28.2
US
Intuitive Surgical Inc
NASDAQ:ISRG
195.9B USD 20.4 71.3 55.4 66.6
US
Boston Scientific Corp
NYSE:BSX
149.7B USD 7.7 53.6 31.7 42.8
US
Stryker Corp
NYSE:SYK
145.9B USD 6.1 50 24.7 29.9
IE
Medtronic PLC
NYSE:MDT
120.1B USD 3.5 25.8 14.3 20.6
DE
Siemens Healthineers AG
XETRA:SHL
55.6B EUR 2.4 25.6 14.3 20
US
Becton Dickinson and Co
NYSE:BDX
53.3B USD 2.5 33.2 12.9 23.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
51.4B USD 12.7 52.1 37.5 41.6
US
Edwards Lifesciences Corp
NYSE:EW
44.6B USD 7.8 10.8 23.7 26
US
Resmed Inc
NYSE:RMD
38B USD 7.4 27.1 19.5 22.2
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
Imagion Biosystems Ltd
ASX:IBX
Average EV/EBITDA: 25.4
Negative Multiple: -15 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
20.3
13%
1.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
55.4
25%
2.2
US
Boston Scientific Corp
NYSE:BSX
31.7
22%
1.4
US
Stryker Corp
NYSE:SYK
24.7
13%
1.9
IE
Medtronic PLC
NYSE:MDT
14.3
8%
1.8
DE
Siemens Healthineers AG
XETRA:SHL
14.3
12%
1.2
US
Becton Dickinson and Co
NYSE:BDX
12.9
11%
1.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
37.5
13%
2.9
US
Edwards Lifesciences Corp
NYSE:EW
23.7
12%
2
US
Resmed Inc
NYSE:RMD
19.5
9%
2.2
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
Imagion Biosystems Ltd
ASX:IBX
Average EV/EBIT: 32.1
Negative Multiple: -15 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
28.2
23%
1.2
US
Intuitive Surgical Inc
NASDAQ:ISRG
66.6
26%
2.6
US
Boston Scientific Corp
NYSE:BSX
42.8
32%
1.3
US
Stryker Corp
NYSE:SYK
29.9
16%
1.9
IE
Medtronic PLC
NYSE:MDT
20.6
17%
1.2
DE
Siemens Healthineers AG
XETRA:SHL
20
17%
1.2
US
Becton Dickinson and Co
NYSE:BDX
23.2
27%
0.9
US
IDEXX Laboratories Inc
NASDAQ:IDXX
41.6
14%
3
US
Edwards Lifesciences Corp
NYSE:EW
26
13%
2
US
Resmed Inc
NYSE:RMD
22.2
12%
1.9

See Also

Summary
IBX intrinsic value, competitors valuation, and company profile.
DCF Valuation
IBX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IBX stock valuation using valuation multiples.
Wall Street Estimates
IBX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IBX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 292,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.